Song Hong Fang
SEC Form 4 insider trading activity
Song Hong Fang has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2025.
On the most recent filing, Song Hong Fang is listed as Director at CG Oncology, Inc. Inside the rolling window, Song Hong Fang reported no open-market purchases and 1 open-market sale totaling $2.8M in CGON.
Companies traded
Other insiders at CGON
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.8M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Song Hong Fang made?
Song Hong Fang has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2025.
Which companies does Song Hong Fang trade?
Song Hong Fang has filed SEC Form 4 disclosures for 1 company, including CGON.
When was Song Hong Fang's most recent SEC Form 4 filing?
Song Hong Fang's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2025.
What is Song Hong Fang's total buy and sell value in the current window?
Inside the rolling retention window, Song Hong Fang bought $0 and sold $2.8M based on SEC Form 4 filings.
What was Song Hong Fang's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 100,000 CGON shares on 2025-09-03, worth $2.8M, per SEC Form 4 filings.